A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum

Amanda S. Machado, Daniela P. Lage, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M.O. Cardoso, Isabela A.G. Pereira, Fernanda F. Ramos, Grasiele S.V. Tavares, Fernanda Ludolf, João A. Oliveira-da-Silva, Raquel S. Bandeira, Aratti C. Simões, Mariana C. Duarte, Jamil S. Oliveira, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

4 Citas (Scopus)

Resumen

Vaccination against visceral leishmaniasis (VL) should be considered as a control measure to protect against disease, and amastigote-specific proteins could help to develop such vaccines, since this parasite form is in contact with the host immune system during the active disease. In this study, a Leishmania amastigote-specific protein, LiHyG, was evaluated as recombinant protein (rLiHyG) as vaccine candidate against Leishmania infantum infection in BALB/c mice. The protein was associated with saponin (rLiHyG/Sap) or Poloxamer 407-based polymeric micelles (rLiHyG/Mic) as adjuvants, and animals receiving saline, saponin or micelle as controls. Immunological and parasitological analyses were performed before (n = 8 per group; as primary endpoint) and after (n = 8 per group; as secondary endpoint) infection. Results showed that, in both endpoints, rLiHyG/Sap and rLiHyG/Mic induced higher levels of IFN-γ, IL-12 and GM-CSF in spleen cell cultures from vaccinated animals, besides elevated presence of IgG2a isotype antibodies. Decreased hepatotoxicity and ‘positive lymphoproliferative response were also found after challenge. Such findings reflected in significantly lower levels of parasite load found in their spleens, livers, bone marrows and draining lymph nodes. In conclusion, rLiHyG associated with Th1-type adjuvant could be considered for future studies as vaccine candidate to protect against VL.

Idioma originalInglés
Número de artículo106412
PublicaciónActa Tropica
Volumen230
DOI
EstadoPublicada - jun. 2022

Huella

Profundice en los temas de investigación de 'A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum'. En conjunto forman una huella única.

Citar esto